http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-082998-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5eb32d34840ccbfdc8e7403686074661 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
| filingDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ab30d6663b65ef2005bd3fcc077c6df |
| publicationDate | 2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-082998-A1 |
| titleOfInvention | PHARMACEUTICAL ASSOCIATION TO TREAT AND / OR PREVENT MIOMA AND / OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR PREVENTION OF MIOMA AND / OR ENDOMETRIOSIS, MEDICATION FOR TREATMENT AND / OR PREPARATION OF MYOMA AND METHOD FOR TREATMENT AND / OR PREVENTION OF MIOMA AND / OR ENDOMETRIOSIS |
| abstract | A combination of resveratrol with progestogens, as well as pharmaceutical compositions and medications that contain such combination, which is useful in the treatment or prevention of myoma and / or endometriosis, which provides reduction in size and control of related symptoms. Said combination may additionally comprise an estrogen component. A method of treatment and a kit are also the subject of the present application. Claim 3: Combination, according to claim 1, characterized in that the progestogen is one or more of the gestin, drospirenone, desogestrel, dienogest or levonogestrel. Claim 10: Combination according to claim 9, characterized in that the estrogen is selected from ethinylestradiol, estradiol, estradiol valerate or mixtures thereof. |
| priorityDate | 2010-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.